Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 89 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

89 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Nov. 14, 2023 XYL S 10b5-1 50,458 $100.57 $5,074,561 336,754 Direct -13.03% Disposed 1.2% (price as of 2026-10-02)
Nov. 14, 2023 XYL S 10b5-1 49,190 $101.13 $4,974,585 287,564 Direct -14.61% Disposed 0.7% (price as of 2026-10-02)
July 3, 2023 XYL S 10b5-1 68,126 $111.53 $7,598,093 319,087 Direct -17.59% Disposed -8.7% (price as of 2026-10-02)
July 3, 2023 XYL S 10b5-1 31,523 $111.82 $3,524,902 287,564 Direct -9.88% Disposed -9.0% (price as of 2026-10-02)
March 13, 2023 XYL S 10b5-1 32,192 $97.88 $3,150,953 311,670 Direct -9.36% Disposed 4.0% (price as of 2026-10-02)
March 13, 2023 XYL S 10b5-1 24,106 $98.60 $2,376,852 287,564 Direct -7.73% Disposed 3.2% (price as of 2026-10-02)
Nov. 9, 2021 XYL S 10b5-1 54,643 $132.91 $7,262,601 237,889 Direct -18.68% Disposed -23.4% (price as of 2026-10-02)
Aug. 10, 2021 XYL S 10b5-1 54,643 $129.53 $7,077,908 237,889 Direct -18.68% Disposed -21.4% (price as of 2026-10-02)
Aug. 6, 2021 XYL S 10b5-1 9,106 $128.24 $1,167,753 237,889 Direct -3.69% Disposed -20.6% (price as of 2026-10-02)
July 9, 2021 XYL S 10b5-1 9,204 $122.56 $1,128,042 246,995 Direct -3.59% Disposed -16.9% (price as of 2026-10-02)
July 9, 2021 XYL S 10b5-1 9,154 $120.77 $1,105,529 256,199 Direct -3.45% Disposed -15.7% (price as of 2026-10-02)

Showing latest 100 of 140 transactions

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Nov. 14, 2023 XYL Non-Qualified Stock Option (Right to Buy) Common Stock (99,648) $35.96 Feb. 24, 2025 99,648 Disposed
July 3, 2023 XYL Non-Qualified Stock Option (Right to Buy) Common Stock (99,649) $35.96 Feb. 24, 2025 99,649 Disposed
March 13, 2023 XYL Stock Options (Right to buy) Common Stock (56,298) $36.81 Feb. 25, 2024 56,298 Disposed
March 1, 2023 XYL Stock Option (Right to Buy) Common Stock (58,070) $101.09 March 1, 2033 58,070 Acquired
March 1, 2022 XYL Stock Option (Right to Buy) Common (78,676) $86.76 March 1, 2032 78,676 Acquired
Nov. 9, 2021 XYL Stock Option (Right to Buy) Common (54,643) $36.81 Feb. 25, 2024 54,643 Disposed
Aug. 10, 2021 XYL Stock Option (Right to Buy) Common (54,643) $36.81 Feb. 25, 2024 54,643 Disposed
March 1, 2021 XYL Stock Option (Right to Buy) Common (64,655) $102.23 March 1, 2031 64,655 Acquired
Feb. 27, 2020 XYL Employee Stock Options (Right to Buy) Common Stock (93,575) $80.66 Feb. 27, 2030 93,575 Acquired
Feb. 20, 2019 XYL Employee Stock Options (Right to Buy) Common Stock (87,925) $74.07 Feb. 20, 2029 87,925 Acquired
Feb. 21, 2018 XYL Employee Stock Options (Right to Buy) Common Stock (85,128) $75.18 Feb. 21, 2028 85,128 Acquired
Feb. 21, 2017 XYL Employee Stock Options (Right to Buy) Common Stock (126,761) $48.33 Feb. 21, 2027 126,761 Acquired
Feb. 24, 2016 XYL Employee Stock Options (Right to Buy) Common Stock (138,581) $37.47 Feb. 24, 2026 138,581 Acquired
Feb. 24, 2015 XYL Employee Stock Options (Right to Buy) Common Stock (199,297) $35.96 Feb. 24, 2025 199,297 Acquired
May 6, 2014 XYL Employee Stock Options Common Stock (165,584) $36.81 Feb. 25, 2024 165,584 Acquired
May 10, 2013 NVRI Stock Appreciation Rights Common Stock, $1.25 par value (220,000) · · 220,000 Acquired
May 10, 2013 NVRI Restricted Stock Units Common Stock, $1.25 par value (34,000) · · 34,000 Acquired
Sept. 10, 2012 NVRI Stock Appreciation Rights Common Stock, $1.25 par value (43,058) $21.37 Sept. 10, 2022 43,058 Acquired
Sept. 10, 2012 NVRI Restricted Stock Units Common Stock, $1.25 par value (5,985) · · 5,985 Acquired
Aug. 18, 2012 JCI Restricted Stock Units Common Shares (12,293) · · 12,293 Disposed
Oct. 12, 2011 JCI Stock Option (Right to Buy) Common Shares (66,800) $44.32 Oct. 11, 2021 66,800 Acquired
Oct. 12, 2011 JCI Performance Share Units Common Shares (31,000) · · 31,000 Disposed
Oct. 12, 2011 JCI Performance Share Units Common Shares (18,000) · · 18,000 Acquired
July 2, 2011 JCI Restricted Stock Units Common Shares (1,998) · · 1,998 Disposed
Nov. 23, 2010 JCI Restricted Stock Units Common shares (16) · · 16 Disposed
Nov. 23, 2010 JCI Restricted Stock Units Common shares (16) · · 16 Acquired
Nov. 21, 2010 JCI Restricted Stock Units Common Shares (2,557) · · 2,557 Disposed
Oct. 12, 2010 JCI Stock Option (Right to Buy) Common Shares (75,400) $37.29 Oct. 11, 2020 75,400 Acquired
Oct. 12, 2010 JCI Performance Share Units Common Shares (20,300) · · 20,300 Acquired
July 2, 2010 JCI Restricted Stock Units Common Shares (1,955) · · 1,955 Disposed
Nov. 21, 2009 JCI Restricted Stock Units Common Shares (2,484) · · 2,484 Disposed
Oct. 1, 2009 JCI Stock Option (Right to Buy) Common Shares (89,900) $33.75 Sept. 30, 2019 89,900 Acquired
Oct. 1, 2009 JCI Performance Share Units Common Shares (25,100) · · 25,100 Acquired
July 2, 2009 JCI Restricted Stock Units Common Shares (1,908) · · 1,908 Disposed
Nov. 21, 2008 JCI Restricted Stock Units Common Shares (2,425) · · 2,425 Disposed
Oct. 7, 2008 JCI Stock Option (Right to Buy) Common Shares (110,800) $29.00 · 110,800 Acquired
Oct. 7, 2008 JCI Performance Share Units Common Shares (31,000) · · 31,000 Acquired
Sept. 30, 2008 JCI Restricted Stock Units Common Shares (4,531) · · 4,531 Disposed
Aug. 18, 2008 JCI Stock Option (Right to Buy) Common Shares (35,000) $44.49 Aug. 17, 2018 35,000 Acquired
Aug. 18, 2008 JCI Restricted Stock Units Common Shares (11,200) · · 11,200 Acquired
July 2, 2007 JCI Stock Option (Right to Buy) Common Shares (17,000) $53.36 July 1, 2017 17,000 Acquired
July 2, 2007 JCI Performance Share Units Common Shares (5,500) · · 5,500 Acquired
July 2, 2007 JCI Restricted Stock Units Common Shares (5,500) · · 5,500 Acquired
June 29, 2007 JCI Stock Option (Right to Buy) Common Shares (11,330) $46.07 Nov. 21, 2015 11,330 Acquired
June 29, 2007 JCI Stock Option (Right to Buy) Common Shares (22,031) $48.14 Nov. 20, 2016 22,031 Acquired
June 29, 2007 JCI Stock Option (Right to Buy) Common Shares (3,482) $44.16 March 25, 2014 3,482 Acquired
June 29, 2007 JCI Stock Option (Right to Buy) Common Shares (20,143) $56.87 March 9, 2015 20,143 Acquired
June 29, 2007 JCI Restricted Stock Units Common Shares (11,645) · · 11,645 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 9 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Oct. 1, 2025 CRH Ordinary Shares 212 Direct
Oct. 1, 2025 CRH Restricted Share Units Award→ Ordinary Shares (932) 932 Direct
June 15, 2007 JCI Common Shares 13,060 Direct
June 15, 2007 JCI Performance Share Units→ Common Shares (7,200) 7,200 Direct
June 15, 2007 JCI Restricted Stock Units→ Common Shares (11,268) 11,268 Direct
June 15, 2007 JCI Stock Option (Right to Buy)→ Common Shares (5,533) 5,533 Direct
June 15, 2007 JCI Stock Option (Right to Buy)→ Common Shares (18,000) 18,000 Direct
June 15, 2007 JCI Stock Option (Right to Buy)→ Common Shares (35,000) 35,000 Direct
June 15, 2007 JCI Stock Option (Right to Buy)→ Common Shares (32,000) 32,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

JCI

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2012 $461,538 · · $934,902 $504,167 · $2,126,873 $5,735,422

XYL

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2023 $1,188,923 · · · $2,466,750 · $276,282 $10,825,450
2022 $1,146,154 · $4,406,169 $1,562,505 $1,797,594 · $1,236,443 $10,148,865
2015 $981,731 · · · $843,960 · $127,798 $6,953,470

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.